$MS news
The latest MS stock news: headlines, filings, AI summaries and sentiment for $MS, updated around the clock.
- Broe Real Estate Group Acquires Luxury Maple Terrace Residences in Dallas
- Ascendis Pharma Reports Q3 Revenue Growth of 90.7% Year-over-Year
- Nvidia Shares Fall Amid Board Meeting Regarding CEO Jensen Huang's Future
- Prudential Wealth Advisors Reports Record Third-Quarter Sales and Asset Growth
- CoreWeave Seeks $4 Billion in Investment-Grade Loan Financing
- Hedge Funds Reduce Exposure to AI Stocks Amid Risk-Cutting Measures
- Morgan Stanley Recommends High-Quality Hyperscaler Bonds Amid AI Debt Volatility
- SpaceX to Attempt First Dual-Stage Catch During Starship Flight 15
- Wall Street Analysts Divided on Nvidia Valuation Amid Price Target Adjustments
- Morgan Stanley Downgrades Halozyme Therapeutics to Equal Weight
- Nvidia Shares Rise in Premarket Trading Following Analyst Downgrades
- Anthropic Bankers Consider Raising IPO Price Range Amid Strong Investor Demand
- Anthropic Launches Australian Retail IPO Ahead of Nasdaq Listing
- Anthropic Sets IPO Price Range of $70-$78 Targeting $1.4 Trillion Valuation
- Disney's Fiscal Fourth Quarter Earnings Expected to Benefit from Extra Reporting Week
- Lucid Group Shares Drop Over 25% in October Amid Production Declines and Increased Debt
- Charles Schwab Expands Crypto Offerings to Include Solana, Avalanche, and Chainlink
- Cloudflare Reports Record Third Quarter Revenue Growth Amid Rising AI-Driven Security Demand
- Blockchain.com Appoints Lisa Nelson and Luis Berruga to Board of Directors
- Fervo Energy Reports Q3 2026 Results: EPS Beats Expectations Amid Revenue Miss
- Trilogy Capital Appoints Former Morgan Stanley Advisor Stephen P. Whitman to San Diego Team
- Yum! Brands Implements AI Solutions at Taco Bell and KFC to Drive Sales and Efficiency
- Qualcomm Shares Drop Despite Beating Earnings Estimates Due to Weak Guidance and Mobile Slump
- Morgan Stanley Analyst Sees Valuation Opportunity in SpaceX Following Revenue Surge
- Revenue Drivers and Q3 Performance Analysis of Major U.S. Banks
- Rep. Josh Gottheimer Discloses AI Stock Purchases Amid Congressional Trading Ban Advocacy
- Morgan Stanley Direct Lending Fund Announces Fee Reductions and New Supplemental Dividend Structure
- University of Michigan November Consumer Sentiment Surpasses Expectations
- ING Seeks Buyers for $500 Million Data Center Loan Portfolio Amid AI Debt Concerns
- Hedge Fund Managers Reduce Holdings and Staff Following October Market Downturn
- Democratic Congressional Victory Influences Oil Prices and Interest Rate Outlook
- AppLovin Shares Surge 31% Following Earnings Beat and Raised Q4 Outlook
- MORGAN STANLEY - 10-Q Filing
- Morgan Stanley Maintains Overweight Rating on Shopify Following Q3 Earnings
- Blackstone Downgrades Credit Forecast for Anthropic Ahead of Potential $2 Trillion IPO
- Harbinger Secures $240 Million in Series D Funding to Expand Electrification Platform
- Wall Street Markets Stabilize Following Midterm Election Rally and Tech Sector Volatility
- Morgan Stanley Downgrades Cisco to Equal-Weight Ahead of Earnings
- Democratic Congressional Control May Increase Regulatory Pressure on AI Data Centers
- Morgan Stanley Lowers Caterpillar Price Target Amid Concerns Over Order Peaks
- Morgan Stanley Downgrades Coinbase to Underweight Following Binance Hack and Slowing Retail Activity
- Ormat Technologies Reports Strong Q3 2026 Results with EPS and Revenue Beats
- Morgan Stanley Downgrades Flagstar Bank to Underweight Amid Turnaround Delays
- AMD Beats Third-Quarter Earnings Estimates Driven by Data Center and AI Growth
- US Futures Rise Following Democratic Gains in Midterm Elections
- Market Outlook: Political Developments in U.S. Elections and Middle East Diplomacy
- Binance Breach Shifts Crypto Market Focus Toward Custody and Cybersecurity Infrastructure
- Verve Group Media SE Appoints Bryan Jennings as Chief Financial Officer
- Morgan Stanley Raises Starbucks Price Target Following Strong Q4 Margin Expansion
- Eli Lilly Shares Surge Toward Record Highs on Strong GLP-1 Drug Demand